Haier Biomedical Unveils Comprehensive Lab Solutions at analytica Munich 2026

Haier Biomedical solidified its standing as a leader in life sciences at analytica 2026 in Munich, unveiling a host of advanced laboratory solutions encapsulated under the theme "In Europe, For Europe." This exhibition marked a significant moment in the company’s localization strategy, emphasizing its dedication to enhancing its operational strengths across Europe.

During the event, Haier Biomedical presented an extensive range of equipment aimed at various sectors such as biobanks, research laboratories, and pharmacies. The showcased technologies included cutting-edge CO₂ incubators, biosafety cabinets, centrifuges, and the highly efficient UltraEco ULT freezer series that features Eco-Drive technology. Notably, these innovations promise to deliver 30% higher efficiency than the industry standards, symbolizing Haier's commitment to sustainability and performance in scientific research.

Transition to Comprehensive Solutions

In transitioning from traditional equipment provision to becoming a holistic provider of laboratory solutions, Haier Biomedical is embracing an end-to-end approach. This includes not just the delivery and set-up of equipment but also the integration of processes such as sample collection, storage, monitoring, and management. The crown jewel of their display was the newly introduced incubator shakers, which are designed for cell suspension culture, offering precise temperature control and continuous oscillation.

This initiative to provide fully integrated workflows addresses pressing issues in operational efficiency, data traceability, and sample integrity. For instance, Haier Biomedical is now deploying automated solutions that help streamline biobanking activities, significantly simplifying the process of managing sensitive biological materials.

A Localized Operations Strategy

Haier Biomedical’s localization strategy is notable for how it adapts to the specific needs of European markets. With a presence established in 18 countries and over 400 local product certifications, the company has tailored its approach to resonate with regional customers while employing more than 40% of its global workforce locally. This strategy has translated into remarkable success: Haier currently holds the No. 1 market share among Chinese brands in several European nations, including Italy, where plans for a new subsidiary are underway to bolster local support and service offerings.

In the UK, the company demonstrated its commitment to rapid response by delivering a complete set of 64 customized biosafety cabinets to Queen Mary University of London within 24 hours. Similarly, in Italy, Haier introduced an intelligent blood management system for local hospitals to enhance healthcare service delivery in the region. Meanwhile, Germany has benefited from the supply of -150°C cryo freezers, leveraging advanced hydrocarbon refrigeration technology for quieter operation and improved research safety.

Towards a Future of Co-Creation

The presentation at analytica 2026 indicates a strategic pivot for Haier Biomedical from merely exporting products to creating an ecosystem focused on collaboration and innovation. Their mantra of "technology + local presence + ecosystem" reflects a holistic vision for growth that resonates with local stakeholders and enhances the overall value proposition in the life sciences sector.

As Haier Biomedical continues to deepen its connections in Europe, it remains focused on establishing itself as a trusted partner in the life sciences community. The company’s clear ambition is to facilitate global expansion driven by local strengths, ultimately aspiring to uphold its reputation as a leading life science brand on the world stage.

For more information about Haier Biomedical and its innovative solutions, please visit Haier Biomedical.